NCT03512756 2024-11-06A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic CancerTyme, IncPhase 2/3 Terminated130 enrolled 13 charts
NCT00201435 2008-05-20Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BCNorwegian Breast Cancer GroupPhase 2/3 Completed224 enrolled